BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31240204)

  • 1. Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma.
    Delgado TC; Lopitz-Otsoa F; Martínez-Chantar ML
    J Hepatocell Carcinoma; 2019; 6():85-91. PubMed ID: 31240204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer.
    Zubiete-Franco I; García-Rodríguez JL; Lopitz-Otsoa F; Serrano-Macia M; Simon J; Fernández-Tussy P; Barbier-Torres L; Fernández-Ramos D; Gutiérrez-de-Juan V; López de Davalillo S; Carlevaris O; Beguiristain Gómez A; Villa E; Calvisi D; Martín C; Berra E; Aspichueta P; Beraza N; Varela-Rey M; Ávila M; Rodríguez MS; Mato JM; Díaz-Moreno I; Díaz-Quintana A; Delgado TC; Martínez-Chantar ML
    EBioMedicine; 2019 Feb; 40():406-421. PubMed ID: 30594553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttranslational regulation of liver kinase B1 in human cancer.
    Hu L; Liu M; Tang B; Li Q; Pan BS; Xu C; Lin HK
    J Biol Chem; 2023 Apr; 299(4):104570. PubMed ID: 36870679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatile Roles of LKB1 Kinase Signaling in Neural Development and Homeostasis.
    Kuwako KI; Okano H
    Front Mol Neurosci; 2018; 11():354. PubMed ID: 30333724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
    MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
    BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new mechanism for LKB1 activation.
    Lee SW; Lin HK
    Mol Cell Oncol; 2018; 5(3):e1035691. PubMed ID: 30250874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LKB1 signaling is activated in CTNNB1-mutated HCC and positively regulates β-catenin-dependent CTNNB1-mutated HCC.
    Charawi S; Just PA; Savall M; Abitbol S; Traore M; Metzger N; Ravinger R; Cavard C; Terris B; Perret C
    J Pathol; 2019 Apr; 247(4):435-443. PubMed ID: 30566242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Kinase B1 Functions as a Regulator for Neural Development and a Therapeutic Target for Neural Repair.
    Huang E; Li S
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma.
    Tan X; Liao Z; Liang H; Chen X; Zhang B; Chu L
    Int J Oncol; 2018 Nov; 53(5):1913-1926. PubMed ID: 30226588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lkb1 regulation of skeletal muscle development, metabolism and muscle progenitor cell homeostasis.
    Shan T; Xu Z; Liu J; Wu W; Wang Y
    J Cell Physiol; 2017 Oct; 232(10):2653-2656. PubMed ID: 28067405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the LKB1/AMPK pathway in tumor invasion and metastasis of cancer cells (Review).
    Li N; Huang D; Lu N; Luo L
    Oncol Rep; 2015 Dec; 34(6):2821-6. PubMed ID: 26398719
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Pons-Tostivint E; Lugat A; Fontenau JF; Denis MG; Bennouna J
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Under-expression of LKB1 is associated with enhanced p38-MAPK signaling in human hepatocellular carcinoma.
    Sha L; Lian F; Li K; Chen C; Zhao Y; He J; Huang S; Wu G
    Int J Clin Exp Pathol; 2018; 11(11):5525-5535. PubMed ID: 31949640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serine/threonine kinase LKB1 controls thymocyte survival through regulation of AMPK activation and Bcl-XL expression.
    Cao Y; Li H; Liu H; Zheng C; Ji H; Liu X
    Cell Res; 2010 Jan; 20(1):99-108. PubMed ID: 20029389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LKB1: cancer, polarity, metabolism, and now fertility.
    Shaw RJ
    Biochem J; 2008 Nov; 416(1):e1-3. PubMed ID: 18939946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.
    Peart T; Ramos Valdes Y; Correa RJ; Fazio E; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Oncotarget; 2015 Sep; 6(26):22424-38. PubMed ID: 26068970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.
    Shukuya T; Yamada T; Koenig MJ; Xu J; Okimoto T; Li F; Amann JM; Carbone DP
    J Thorac Oncol; 2019 Jun; 14(6):1061-1076. PubMed ID: 30825612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the structural dynamics of Liver kinase B1 (LKB1) by the binding of STe20 Related Adapterα (STRADα) and Mouse protein 25α (MO25α) co-activators.
    Rungsung I; Ramaswamy A
    J Biomol Struct Dyn; 2017 Apr; 35(5):1138-1152. PubMed ID: 27160967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
    Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
    Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.